PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

SIV shrugs off antibodies in vaccinated monkeys

A puzzle in AIDS vaccine research

2015-08-11
(Press-News.org) New research on monkeys vaccinated against HIV's relative SIV calls into question an idea that has driven AIDS vaccine work for years. The assumption: a protective vaccine only needs to stimulate moderate levels of antibodies that neutralize the virus.

However, scientists at Yerkes National Primate Research Center and the Emory Vaccine Center have found that when SIV manages to infect vaccinated monkeys that have potent neutralizing antibodies in their blood, the virus appears to shrug the antibodies off. No stealthy escape by mutation was necessary.

The results were published Monday, August 10 by PNAS.

While published studies have shown that experimental vaccines can protect a majority of monkeys from repeated challenge with SIV, the Yerkes and Vaccine Center team's findings are sobering and puzzling, says senior author Cynthia Derdeyn, PhD, professor of pathology and laboratory medicine at Emory University School of Medicine and Yerkes National Primate Research Center.

In an infected individual, HIV (or SIV) is always mutating; Derdeyn's ongoing research shows how HIV changes in newly infected humans in order to escape pressure from the immune system.

"We were surprised because we expected the virus that breaks through to be resistant to the vaccine-induced antibodies," she says. "We need to know more about whether antibodies are present and protective on the mucosal surfaces where transmission occurs, and whether active vaccination might be increasing susceptibility to infection."

Derdeyn's work is an extension of several vaccine studies Rama Amara, PhD, and his colleagues conducted at Yerkes in which rhesus macaques were immunized and then repeatedly challenged with SIV with a schedule that is consistent from study to study. After 12 challenges, 100 percent of control animals became infected, but with the most effective vaccination regimens, nearly 70 percent remained uninfected.

"There is a protective effect, but it's incomplete," Derdeyn says. "So we want to know what's happening in those animals where the virus gets through the barrier."

Researchers obtained samples of the viral strain that established infection in 14 vaccinated-yet-infected monkeys. The infections recapitulated the "genetic bottleneck" effect seen in human HIV transmission, where a single viral variant establishes infection. In 13 of 14 cases, antibodies from the monkeys' blood could neutralize the particular viral variant that established infection.

According to the authors, possible explanations could be: neutralizing antibodies are present in the blood, but not in sufficient levels in mucosal secretions immunization may increase the number of target T cells for the virus in mucosal tissues and a balance between protective antibody response and target cell frequency ultimately determines protection in vitro antibody tests don't reflect how in vivo transmission occurs

Derdeyn's team is continuing with an investigation of how SIV's infectivity differs depending on whether viral challenge occurs rectally or vaginally.

The first author of the paper is lead research specialist Samantha Burton in the Derdeyn lab.

The research was supported by the National Institute of Allergy and Infectious Diseases (R01AI58706, U19AI096187, P01AI88575), and the NIH's Office of Research Infrastructure Programs (P51RR000165 and P51OD011132 - primate centers).

INFORMATION:



ELSE PRESS RELEASES FROM THIS DATE:

C-section could impact baby's ability to focus: York U study

2015-08-11
TORONTO, August 11 2015 -- There can be a difference in how well babies focus attention on an object of interest, depending on whether they were delivered by natural birth or Caesarean section, a recent York University study indicates. "Our research has revealed that being born by a C-section slows a baby's spatial attention, which plays a role in its ability to focus on a particular area or object of interest," says Professor Scott Adler in the Department of Psychology, Faculty of Health at YorkU. According to Adler and his co-researcher Audrey Wong Kee-You, very ...

Cutting costs: Sustainability matters even in complex networks

2015-08-11
Every day, we expend energy when we con­trol the net­works in our lives. For example, to drive our car, we utilize a net­work whose com­po­nents include the car's accel­er­ator, steering wheel, and brake. Knowing how much that effort "costs" can help deter­mine which com­po­nents to manipulate--and to what degree--to ensure the smoothest, safest ride as you acclerate from 55 to 90 miles per hour. On Monday, North­eastern researchers revealed just such a mea­suring strategy in a new paper pub­lished in Nature Physics. "We ...

New report recommends research priorities for Antarctic and Southern Ocean science

2015-08-11
WASHINGTON -- An initiative to better understand how melting ice sheets will contribute to sea-level rise, efforts to decode the genomes of organisms to understand evolutionary adaptations, and a next-generation cosmic microwave background experiment to address fundamental questions about the origin of the universe are the top research goals for Antarctic and Southern Ocean science recommended in a new report from the National Academies of Sciences, Engineering, and Medicine. The report, which offers a strategic vision to guide the U.S. Antarctic Program at the National ...

Vortioxetine in depression: No hint of added benefit

2015-08-11
Vortioxetine (trade name: Brintellix) has been approved since December 2013 for the treatment of depression in adults, but did not become actually available before May 2015. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether this drug offers an added benefit over the appropriate comparator therapy. Such an added benefit cannot be derived from the dossier because it contained no data evaluable for the assessment. SSRI is drug component of comparator therapy The Federal Joint Committee (G-BA) distinguished between ...

Insulin degludec plus liraglutide: No hint of added benefit in type 2 diabetes

2015-08-11
The fixed-ratio combination of the two drugs insulin degludec and liraglutide (trade name: Xultophy) has been approved since September 2014 for adults with type 2 diabetes mellitus. It is given as an injection in addition to other blood-glucose lowering drugs when these alone or in combination with basal insulin are insufficient to lower blood glucose levels. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether this fixed-ratio combination offers an added benefit over the appropriate comparator therapy. Such ...

One technique therapists use that really helps depressed patients

2015-08-11
COLUMBUS, Ohio - Some depressed patients may be hoping for answers from their therapists, but a new study suggests questions may be the key. Researchers examined how cognitive therapy for depression achieves its positive effects. Their study is the first to show that depressed patients see substantial improvements in their depressive symptoms when their therapists use a technique called "Socratic questioning." These are a series of guided questions in which the therapist asks a patient to consider new perspectives on themselves and their place in the world. "People ...

C-sections could influence babies' ability to focus

2015-08-11
Being delivered through a caesarean section influences at least one form of babies' ability to concentrate. It slows their spatial attention, which plays a role in how well they are able to prioritize and focus on a particular area or object that is of interest. These are the findings of Scott Adler and Audrey Wong-Kee-You of York University in Canada, published in Springer's journal Attention, Perception, & Psychophysics. Very early birth factors such as birth weight and a mother's age impact the development of a child. However, very little is known about how the actual ...

Chitin of insects and crustaceans found to be active against pathogenic microorganisms

2015-08-11
The study specifically concentrated on chitosan extracted from chitin in the carapaces of insects and crustaceans. The biopolymer was first discovered in 1859 but only recently has it become possible to establish its production within desired parameters, when researchers from the Bioengineering Center of RAS designed narrow-dispersion chitosan. This gave an opportunity to modern scientists to customize the biological properties of certain types of the biopolymer. "We found that some forms of chitosan are toxic. They can disrupt the membranes of pathogenic microorganisms" ...

Researchers develop fast test for invasive carp

2015-08-11
A Case Western Reserve University graduate student turned a research paper into a field test that quickly determines whether an Asian carp invading Lake Erie is sterile or can reproduce. If proven successful, the technique could save money and time in the effort to keep the carp out of the Great Lakes, where the fish could grow unchecked and devour food supplies and habitat critical to native species.. Grass carp, the species Ctenopharyngodon idella, have been introduced throughout the Midwest and South to clear ponds choked with weeds. Also called the white amur, fertile ...

NYU study examines top high school students' stress and coping mechanisms

2015-08-11
Over time selective high schools have oriented themselves to address a context of increasingly competitive college admissions School work, college applications, extracurricular activities, and parental expectations all contribute to teenagers' stress Youth, schools, and experts identified substance use as a common strategy for coping with stress "School, homework, extracurricular activities, sleep, repeat--that's what it can be for some of these students," says Noelle Leonard, PhD, a senior research scientist at the New York University College of Nursing (NYUCN). ...

LAST 30 PRESS RELEASES:

Global cervical cancer vaccine roll-out shows it to be very effective in reducing cervical cancer and other HPV-related disease, but huge variations between countries in coverage

Negativity about vaccines surged on Twitter after COVID-19 jabs become available

Global measles cases almost double in a year

Lower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard regimen

Personalised “cocktails” of antibiotics, probiotics and prebiotics hold great promise in treating a common form of irritable bowel syndrome, pilot study finds

Experts developing immune-enhancing therapies to target tuberculosis

Making transfusion-transmitted malaria in Europe a thing of the past

Experts developing way to harness Nobel Prize winning CRISPR technology to deal with antimicrobial resistance (AMR)

CRISPR is promising to tackle antimicrobial resistance, but remember bacteria can fight back

Ancient Maya blessed their ballcourts

Curran named Fellow of SAE, ASME

Computer scientists unveil novel attacks on cybersecurity

Florida International University graduate student selected for inaugural IDEA2 public policy fellowship

Gene linked to epilepsy, autism decoded in new study

OHSU study finds big jump in addiction treatment at community health clinics

Location, location, location

Getting dynamic information from static snapshots

Food insecurity is significant among inhabitants of the region affected by the Belo Monte dam in Brazil

The Society of Thoracic Surgeons launches new valve surgery risk calculators

Component of keto diet plus immunotherapy may reduce prostate cancer

New circuit boards can be repeatedly recycled

Blood test finds knee osteoarthritis up to eight years before it appears on x-rays

April research news from the Ecological Society of America

Antimicrobial resistance crisis: “Antibiotics are not magic bullets”

Florida dolphin found with highly pathogenic avian flu: Report

Barcodes expand range of high-resolution sensor

DOE Under Secretary for Science and Innovation visits Jefferson Lab

Research expo highlights student and faculty creativity

Imaging technique shows new details of peptide structures

MD Anderson and RUSH unveil RUSH MD Anderson Cancer Center

[Press-News.org] SIV shrugs off antibodies in vaccinated monkeys
A puzzle in AIDS vaccine research